AmirAli Talasaz is co-CEO of precision oncology company Guardant Health, which he co-founded in 2012 with Helmy Eltoukhy. Prior to co-founding Guardant Health, Talasaz was senior director of diagnostics research at Illumina and led the efforts for emerging clinical applications of next-generation genomic analysis. Before Illumina, he founded Auriphex Biosciences, which focused on purification and genetic analysis of circulating tumor cells for cancer management. (Guardant Health is a 2025 Festival Underwriter)
Previously
2023 Health
In Search of Disease: Opportunities and Risks
Remarkable screening and diagnostic tools are being developed so that disease can be identified in its earliest stages, when it is most treatable, and disease subtypes can be...
Video — 49m 29s